These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6200964)

  • 1. Relationship between saliva and serum quinidine concentrations and suppression of ventricular premature beats.
    Ueda CT; Beckmann PJ; Dzindzio BS
    Ther Drug Monit; 1984; 6(1):43-9. PubMed ID: 6200964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of ventricular premature beat suppression to serum quinidine concentraton determined by a new and specific assay.
    Carliner NH; Fisher ML; Crouthamel WG; Narang PK; Plotnick GD
    Am Heart J; 1980 Oct; 100(4):483-9. PubMed ID: 7415936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quinidine saliva concentrations: absence of correlation with serum concentrations at steady state.
    Narang PK; Carliner NH; Fisher ML; Crouthamel WG
    Clin Pharmacol Ther; 1983 Nov; 34(5):695-702. PubMed ID: 6627830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between quinidine concentrations measured in saliva and erythrocytes, and in serum.
    Yosselson-Superstine S; Yanuka Y; Ishai S
    Int J Clin Pharmacol Ther Toxicol; 1982 Apr; 20(4):181-6. PubMed ID: 7076348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of control steady-state serum digoxin levels for predicting serum digoxin concentration after quinidine administration.
    Friedman HS; Chen TS
    Am Heart J; 1982 Jul; 104(1):72-6. PubMed ID: 6178280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of sustained-release quinidines given twice daily to patients with ventricular ectopy.
    Lehmann CR; Boran KJ; Kruyer WB; Van Reet RE; Scoville GS; Pierson WP; Melikian AP; Crowe JT; Wright GJ
    J Clin Pharmacol; 1986; 26(8):598-604. PubMed ID: 3793950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Saliva-serum theophylline concentrations: substantial intrapatient and interpatient variation in predicting serum concentrations.
    Uden DL; Miller KW; Strand LM; Johnson PB; Zaske DE
    Ther Drug Monit; 1981; 3(2):143-50. PubMed ID: 7268827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diurnal oscillations in the serum and salivary levels of quinidine.
    Rao BR; Rambhau D
    Arzneimittelforschung; 1995 Jun; 45(6):681-3. PubMed ID: 7646570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variability of spontaneous and exercise-induced ventricular arrhythmias in the absence and presence of treatment with acebutolol or quinidine.
    Shapiro W; Park J; Koch GG
    Am J Cardiol; 1982 Feb; 49(2):445-54. PubMed ID: 6174041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steady-state serum quinidine concentration: role in prophylactic therapy following acute myocardial infarction.
    Halkin H; Vered Z; Millman P; Rabinowitz B; Neufeld HN
    Isr J Med Sci; 1979 Jul; 15(7):583-7. PubMed ID: 478822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of quinidine on serum digoxin concentration: a prospective study.
    Mungall DR; Robichaux RP; Perry W; Scott JW; Robinson A; Burelle T; Hurst D
    Ann Intern Med; 1980 Nov; 93(5):689-93. PubMed ID: 7212476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative hemodynamic effects of mexiletine and quinidine in patients with severe left ventricular dysfunction.
    Gottlieb SS; Weinberg M
    Am Heart J; 1991 Nov; 122(5):1368-74. PubMed ID: 1951002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Plasma level studies of quinidine retard, their significance for dosage and onset of effect].
    Guckenbiehl W; Just H; Olbermann M; Lang KF
    Med Klin; 1976 Apr; 71(14):586-92. PubMed ID: 57566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lorcainide. A comparative trial with quinidine gluconate in patients with previously untreated ventricular arrhythmias.
    Falk RH; O'Brien JL
    Chest; 1984 Oct; 86(4):537-40. PubMed ID: 6383741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of quinidine and mexiletine on the adaptation of ventricular refractoriness to an increase in rate.
    Rosenheck S; Schmaltz S; Kadish AH; Summitt J; Morady F
    Am Heart J; 1991 Feb; 121(2 Pt 1):512-7. PubMed ID: 1990756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indecainide compared with quinidine for chronic stable ventricular arrhythmias secondary to coronary artery disease or to cardiomyopathy.
    Giardina EG; Zaim S; Saroff AL; Kirschenbaum M
    Am J Cardiol; 1987 Sep; 60(7):584-9. PubMed ID: 2442993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [An experimental model for the rational treatment of arrhythmias: a clinical study with quinidine].
    Pelosi G; Duca G; Bareggi SR; Pirola R; Hadëri B
    G Ital Cardiol; 1993 Aug; 23(8):777-86. PubMed ID: 8119501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous quinidine: relations among concentration, tachyarrhythmia suppression and electrophysiologic actions with inducible sustained ventricular tachycardia.
    Duff HJ; Wyse DG; Manyari D; Mitchell LB
    Am J Cardiol; 1985 Jan; 55(1):92-7. PubMed ID: 3966404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of salivary concentrations in the prediction of serum caffeine and theophylline concentrations in premature infants.
    Khanna NN; Bada HS; Somani SM
    J Pediatr; 1980 Mar; 96(3 Pt 1):494-9. PubMed ID: 7359248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of digoxin, quinidine, and disopyramide interactions in rats utilizing parotid saliva, blood, and other tissues.
    DiGregorio GJ; Piraino AJ; Ruch EK; Basseches PJ
    J Pharm Sci; 1982 Feb; 71(2):211-3. PubMed ID: 7062248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.